S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases
Psoriasis is one of the most common inflammatory skin diseases affecting about 1–3% of the population. One of the characteristic abnormalities in psoriasis is the excessive production of antimicrobial peptides and proteins, which play an essential role in the pathogenesis of the disease. Antimicrobi...
Main Authors: | Katarzyna Kurpet, Grażyna Chwatko |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
MDPI AG
2022-10-01
|
סדרה: | Molecules |
נושאים: | |
גישה מקוונת: | https://www.mdpi.com/1420-3049/27/19/6640 |
פריטים דומים
-
Study of serum levels and skin expression of S100B protein in psoriasis
מאת: Samar Abdallah M. Salem, et al.
יצא לאור: (2017-06-01) -
S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
מאת: Natsuko Saito-Sasaki, et al.
יצא לאור: (2023-10-01) -
Pathogenic role of S100 proteins in psoriasis
מאת: Huifang Liang, et al.
יצא לאור: (2023-06-01) -
S100 Proteins As an Important Regulator of Macrophage Inflammation
מאת: Chang Xia, et al.
יצא לאור: (2018-01-01) -
Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
מאת: April W. Armstrong, et al.
יצא לאור: (2024-09-01)